Park Dental Partners, a dental support organization serving affiliated practices, has leaned on acquisitions for growth since its late-2025 IPO. This report offers a useful check on whether revenue momentum can continue while the company absorbs higher labor costs and the added expenses of being public. I think investors will focus on whether organic same-practice trends can offset the margin impact from rising salaries and benefits. The results also provide an early read on how the recently completed Village Family Dental acquisition could influence the fourth quarter and next year.
For the third quarter ended September 30, 2026, PARK posted revenue of $64.9 million, up 6.0% from $61.3 million a year ago. Net income increased 36.1% to $1.7 million, yet diluted EPS dropped to $0.27 from $0.72, largely due to a higher share count after the IPO. Adjusted diluted EPS came in at $0.57, below the prior-year $1.19 but above consensus. Adjusted EBITDA fell 6.2% to $5.0 million, narrowing the margin to 7.7% from 8.7%. Gross margin declined 280 basis points to 12.6% amid higher salaries and benefits. Same-practice revenue growth eased to 3.2% from 9.9%, while affiliated doctors rose 3.2% to 225. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Shares of PARK moved lower after the release, falling roughly 3% to 4% in after-hours and next-day trading. The response appears tied to the margin compression and slower same-practice growth, even though revenue stayed on track. Adjusted EPS beat estimates, but the year-over-year drop in profitability measures and thinner gross margins highlighted ongoing cost pressures from labor, benefits, and public-company overhead. Earlier sentiment had drawn support from a solid second quarter and a bullish price target, yet the softer margin picture seems to have cooled some enthusiasm.
Looking ahead, several factors stand out for PARK. The Village Family Dental acquisition, closed in November 2026, brings about 48 doctors and 12 locations in North Carolina and should begin contributing revenue in the fourth quarter and into 2027. Management continues to view M&A as the main growth driver, so the pace and quality of future deals will remain central. Cost trends warrant attention as well. Higher salaries and benefits weighed on margins this quarter, and any further wage pressure could keep profitability constrained. At the same time, same-practice revenue growth slowed to 3.2%, so investors will monitor whether patient volumes and provider productivity can pick up. Balance-sheet flexibility to fund expansion without excessive leverage also matters. None of this is a price forecast, but these fundamentals are worth tracking.
From what I see, tools like Tickeron’s AI Screener can help cut through the noise when comparing companies such as PARK to peers. The platform lets users filter by fundamentals, technical patterns, and performance metrics, which I find useful for spotting comparable opportunities in healthcare services without spending hours on manual screens. It serves as a practical starting point when building out research on names in this space.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
PARK saw its Momentum Indicator move above the 0 level on November 06, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 15 similar instances where the indicator turned positive. In 14 of the 15 cases, the stock moved higher in the following days. The odds of a move higher are at 90%.
The Moving Average Convergence Divergence (MACD) for PARK just turned positive on October 28, 2026. Looking at past instances where PARK's MACD turned positive, the stock continued to rise in 5 of 6 cases over the following month. The odds of a continued upward trend are 83%.
PARK moved above its 50-day moving average on November 09, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for PARK crossed bullishly above the 50-day moving average on November 06, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 3 of 3 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
Following a +5.10% 3-day Advance, the price is estimated to grow further. Considering data from situations where PARK advanced for three days, in 45 of 49 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PARK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.
PARK broke above its upper Bollinger Band on October 30, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for PARK entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 13 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.172) is normal, around the industry mean (204.532). P/E Ratio (-26.472) is within average values for comparable stocks, (21.572). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.154) among similar stocks. P/S Ratio (0.381) is also within normal values, averaging (2.688).
The Tickeron Price Growth Rating for this company is 46 (best 1 - 100 worst), indicating steady price growth. PARK’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 99 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PARK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry HospitalNursingManagement